Annual Retained Earnings
-$157.56 M
+$5.53 M+3.39%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual retained earnings is -$157.56 million, with the most recent change of +$5.53 million (+3.39%) on December 1, 2023.
- ORMP annual retained earnings is now -18921.61% below its all-time high of -$828.30 thousand, reached on August 31, 2005.
Performance
ORMP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$166.43 M
-$19.62 M-13.36%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly retained earnings is -$166.43 million, with the most recent change of -$19.62 million (-13.36%) on September 1, 2024.
- Over the past year, ORMP quarterly retained earnings has dropped by -$8.87 million (-5.63%).
- ORMP quarterly retained earnings is now -19855.28% below its all-time high of -$834.00 thousand, reached on November 30, 2005.
Performance
ORMP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ORMP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | -5.6% |
| 3 y3 years | - | -12.8% |
| 5 y5 years | -94.3% | -105.2% |
ORMP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.5% | +3.4% | -35.6% | +2.6% |
| 5 y | 5-year | -94.3% | +3.4% | -99.0% | +2.6% |
| alltime | all time | <-9999.0% | +3.4% | <-9999.0% | +2.6% |
Oramed Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$166.43 M(+13.4%) |
| Jun 2024 | - | -$146.81 M(-5.9%) |
| Mar 2024 | - | -$156.02 M(-1.0%) |
| Dec 2023 | -$157.56 M(-3.4%) | -$157.56 M(-7.8%) |
| Sep 2023 | - | -$170.89 M(+1.9%) |
| Jun 2023 | - | -$167.67 M(+0.7%) |
| Mar 2023 | - | -$166.48 M(+2.1%) |
| Dec 2022 | -$163.08 M(+28.9%) | -$163.08 M(+5.5%) |
| Sep 2022 | - | -$154.54 M(+4.8%) |
| Jun 2022 | - | -$147.48 M(+7.7%) |
| Mar 2022 | - | -$136.94 M(+11.6%) |
| Dec 2021 | -$126.52 M(+10.2%) | - |
| Nov 2021 | - | -$122.74 M(+6.9%) |
| Aug 2021 | -$114.85 M(+24.0%) | -$114.85 M(+6.3%) |
| May 2021 | - | -$108.00 M(+5.1%) |
| Feb 2021 | - | -$102.79 M(+4.7%) |
| Nov 2020 | - | -$98.18 M(+6.0%) |
| Aug 2020 | -$92.61 M(+14.2%) | -$92.61 M(+3.3%) |
| May 2020 | - | -$89.62 M(+2.6%) |
| Feb 2020 | - | -$87.33 M(+4.4%) |
| Nov 2019 | - | -$83.65 M(+3.1%) |
| Aug 2019 | -$81.10 M(+17.2%) | -$81.10 M(+2.9%) |
| May 2019 | - | -$78.82 M(+5.4%) |
| Feb 2019 | - | -$74.75 M(+5.2%) |
| Nov 2018 | - | -$71.05 M(+2.6%) |
| Aug 2018 | -$69.22 M(+22.5%) | -$69.22 M(+4.4%) |
| May 2018 | - | -$66.30 M(+7.0%) |
| Feb 2018 | - | -$61.94 M(+4.9%) |
| Nov 2017 | - | -$59.03 M(+4.5%) |
| Aug 2017 | -$56.50 M(+22.8%) | -$56.50 M(+5.0%) |
| May 2017 | - | -$53.80 M(+3.8%) |
| Feb 2017 | - | -$51.84 M(+6.5%) |
| Nov 2016 | - | -$48.65 M(+5.7%) |
| Aug 2016 | -$46.02 M(+31.3%) | -$46.02 M(+11.5%) |
| May 2016 | - | -$41.26 M(+5.1%) |
| Feb 2016 | - | -$39.26 M(+4.9%) |
| Nov 2015 | - | -$37.44 M(+6.8%) |
| Aug 2015 | -$35.05 M | -$35.05 M(+6.4%) |
| May 2015 | - | -$32.94 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | -$31.35 M(+5.5%) |
| Nov 2014 | - | -$29.72 M(+6.8%) |
| Aug 2014 | -$27.82 M(+25.7%) | -$27.82 M(+6.2%) |
| May 2014 | - | -$26.19 M(+7.5%) |
| Feb 2014 | - | -$24.36 M(+4.8%) |
| Nov 2013 | - | -$23.25 M(+5.1%) |
| Aug 2013 | -$22.12 M(+23.7%) | -$22.12 M(+3.7%) |
| May 2013 | - | -$21.33 M(+6.3%) |
| Feb 2013 | - | -$20.08 M(+6.5%) |
| Nov 2012 | - | -$18.85 M(+5.4%) |
| Aug 2012 | -$17.89 M(+23.0%) | -$17.89 M(+8.0%) |
| May 2012 | - | -$16.56 M(+3.4%) |
| Feb 2012 | - | -$16.01 M(+6.6%) |
| Nov 2011 | - | -$15.03 M(+3.3%) |
| Aug 2011 | -$14.55 M(+12.0%) | -$14.55 M(+5.6%) |
| May 2011 | - | -$13.77 M(-3.2%) |
| Feb 2011 | - | -$14.23 M(+4.7%) |
| Nov 2010 | - | -$13.59 M(+4.6%) |
| Aug 2010 | -$12.99 M(+29.7%) | -$12.99 M(+9.9%) |
| May 2010 | - | -$11.82 M(+7.3%) |
| Feb 2010 | - | -$11.01 M(+3.7%) |
| Nov 2009 | - | -$10.62 M(+6.1%) |
| Aug 2009 | -$10.01 M(+38.1%) | -$10.01 M(+4.2%) |
| May 2009 | - | -$9.61 M(+5.6%) |
| Feb 2009 | - | -$9.09 M(+7.8%) |
| Nov 2008 | - | -$8.44 M(+16.4%) |
| Aug 2008 | -$7.25 M(+61.8%) | -$7.25 M(+21.0%) |
| May 2008 | - | -$5.99 M(+15.9%) |
| Feb 2008 | - | -$5.17 M(+7.0%) |
| Nov 2007 | - | -$4.83 M(+7.8%) |
| Aug 2007 | -$4.48 M(+260.4%) | -$4.48 M(+130.1%) |
| May 2007 | - | -$1.95 M(+17.9%) |
| Feb 2007 | - | -$1.65 M(+25.1%) |
| Nov 2006 | - | -$1.32 M(+6.2%) |
| Aug 2006 | -$1.24 M(+50.1%) | -$1.24 M(+29.1%) |
| May 2006 | - | -$962.50 K(+15.2%) |
| Feb 2006 | - | -$835.60 K(+0.2%) |
| Nov 2005 | - | -$834.00 K |
| Aug 2005 | -$828.30 K | - |
FAQ
- What is Oramed Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual retained earnings year-on-year change?
- What is Oramed Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly retained earnings year-on-year change?
What is Oramed Pharmaceuticals annual retained earnings?
The current annual retained earnings of ORMP is -$157.56 M
What is the all time high annual retained earnings for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual retained earnings is -$828.30 K
What is Oramed Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ORMP annual retained earnings has changed by +$5.53 M (+3.39%)
What is Oramed Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ORMP is -$166.43 M
What is the all time high quarterly retained earnings for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly retained earnings is -$834.00 K
What is Oramed Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ORMP quarterly retained earnings has changed by -$8.87 M (-5.63%)